Dan Chevallard is the founder of Viracta Therapeutics. Latest round: Series D. Backed by Taiwania Capital Management. Based in San Diego, United States.
Dan Chevallard is a financial executive who previously served as Chief Financial Officer and currently as Chief Operating Officer and Chief Financial Officer at Viracta Therapeutics. He joined Viracta from Regulus Therapeutics Inc. where he held various key positions.
Full founder directory · Investor directory · Company funding database · Fundraising library